Correlation Between Apogee Enterprises and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both Apogee Enterprises and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Enterprises and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Enterprises and Spyre Therapeutics, you can compare the effects of market volatilities on Apogee Enterprises and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Enterprises with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Enterprises and Spyre Therapeutics.
Diversification Opportunities for Apogee Enterprises and Spyre Therapeutics
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Apogee and Spyre is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Enterprises and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Apogee Enterprises is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Enterprises are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Apogee Enterprises i.e., Apogee Enterprises and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between Apogee Enterprises and Spyre Therapeutics
Given the investment horizon of 90 days Apogee Enterprises is expected to generate 0.46 times more return on investment than Spyre Therapeutics. However, Apogee Enterprises is 2.17 times less risky than Spyre Therapeutics. It trades about 0.3 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.13 per unit of risk. If you would invest 7,484 in Apogee Enterprises on September 1, 2024 and sell it today you would earn a total of 937.00 from holding Apogee Enterprises or generate 12.52% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apogee Enterprises vs. Spyre Therapeutics
Performance |
| Timeline |
| Apogee Enterprises |
| Spyre Therapeutics |
Apogee Enterprises and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apogee Enterprises and Spyre Therapeutics
The main advantage of trading using opposite Apogee Enterprises and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Enterprises position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.| Apogee Enterprises vs. Quanex Building Products | Apogee Enterprises vs. Janus International Group | Apogee Enterprises vs. Interface | Apogee Enterprises vs. Azek Company |
| Spyre Therapeutics vs. Tff Pharmaceuticals | Spyre Therapeutics vs. Eliem Therapeutics | Spyre Therapeutics vs. Inhibrx | Spyre Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |